Weaver Consulting Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Weaver Consulting Group's ABBV Position: Q3 2026 in Review
Weaver Consulting Group increased its AbbVie (ABBV) stake by 6.8% in Q3 2026, buying an estimated $21.3K and bringing the position to 1,311 shares worth $343K. The position accounts for 0.07% of the portfolio, ranked #217.
Weaver Consulting Group first reported a position in ABBV in Q1 2019 and has held it in 20 quarters since. 1,347 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Weaver Consulting Group held 1,311 shares of AbbVie worth $343K as of Q3 2026.
- Weaver Consulting Group bought 83 AbbVie shares in Q3 2026, an estimated $21.3K.
- AbbVie made up 0.07% of Weaver Consulting Group's portfolio in Q3 2026, its #217 holding.
- Weaver Consulting Group first reported a position in AbbVie in Q1 2019 and has held it in 20 quarters since.
- 1,347 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Weaver Consulting Group's 13F filing for Q3 2026, filed 7 Oct 2026.